Search

Refine Search

Categories
Published Date
Keywords
    Authors

    695 results for search term: covid

    Category: Biological and Medicinal Chemistry
    , Title:

    COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database

    , Authors: Daniel Korn, Tesia Bobrowski, Michael Li, Yaphet Kebede, Patrick Wang, Phillips Owen, Gaurav Vaidya, Eugene Muratov, Rada Chirkova, Cristopher Bizon, Alexander Tropsha

    Extract found to contain search terms

    In response to the COVID -19 pandemic, we established COVID -KOP, a new knowledgebase integrating the existing ROBOKOP biomedical knowledge graph with information from recent biomedical literature on COVID -19 annotated in the CORD-19 collection. COVID -KOP can be used effectively to test new hypotheses concerning repurposing of known drugs and clinical drug candidates against COVID -19. COVID

    600
    Downloads
    Category: Analytical Chemistry
    , Title:

    Possible Drug Candidates for COVID-19

    , Authors: Navan Chauhan

    Extract found to contain search terms

    COVID

    4,011
    Downloads
    Category: Biological and Medicinal Chemistry
    , Title:

    The NIH Lipo-COVID Study: A pilot NMR investigation of lipoprotein subfractions and other metabolites in patients with severe COVID-19.

    , Authors: Rami A. Ballout, Hyesik Kong, Maureen Sampson, James D. Otvos, Andrea Cox, Sean Agbor-Enoh, Alan T. Remaley

    Extract found to contain search terms

    Patients with severe COVID -19 have been reported to have low levels of total cholesterol, HDL-cholesterol, and LDL-cholesterol, but elevated levels of triglycerides. However, detailed characterization of particle number and size of the different plasma lipoproteins in patients with COVID -19 has yet to be reported. In this pilot investigational study, NMR spectroscopy was used to characterize lipoprotein particle numbers and sizes, as well as various metabolites, in 32 patients with severe COVID

    147
    Downloads
    Category: Biological and Medicinal Chemistry
    , Title:

    Gliptin Repurposing for COVID-19

    , Authors: Matthew Groves, Alexander Domling, Angel Jonathan Ruiz Moreno, Atilio Reyes Romero, Constantinos Neochoritis, Marco Velasco-Velázquez

    Extract found to contain search terms

    Drug repurposing aims to discover novel indications for already approved 34 drugs.3 The overwhelming advantage of drug repurposing is the much faster clinical approval, due to 35 already extensive knowledge of the physicochemical properties and behavior of the drug in humans. 36 Therefore, many groups have pursued a drug repurposing approach. This has led to several promising 37 drugs which are currently tested for COVID -19 in humans, including Favipiravir, Remdesivir, HIV protease 38 inhibitors, chloroquine or Tozilizumab.4,5 So far, however, none showed more than promising activity 39 based on low numbers of patients per trial. Additionally, a combination of Lopinavir and Ritonavir 40 (Kaletra®) – effective for HIV infection – failed in ~200 severe COVID

    798
    Downloads
    Category: Biological and Medicinal Chemistry
    , Title:

    Text and Network-Mining for COVID-19 Intervention Studies

    , Authors: Aditya Rao, VG Saipradeep, Thomas Joseph, Sujatha Kotte, Naveen Sivadasan, Rajgopal Srinivasan

    Extract found to contain search terms

    Amongst the novel repurposing drugs predicted, laninamivir and paritaprevir are possible COVID -19 anti-viral drugs while pranlukast was postulated to be a candidate for managing severe respiratory symptoms in COVID

    742
    Downloads
    Category: Biological and Medicinal Chemistry
    , Title:

    Data-Driven Drug Repurposing for COVID-19

    , Authors: Raghvendra Mall, Abdurrahman Elbasir, Hossam Al Meer, Sanjay Chawla, Ehsan Ullah

    Extract found to contain search terms

    Disclaimer: Our models are computational and the drugs suggested should not be taken for treating COVID

    443
    Downloads
    Category: Biological and Medicinal Chemistry
    , Title:

    Repurposing of SARS Inhibitors Against COVID 19

    , Authors: Priyanka Rajbhar, Dikshant Singh, Ruchi Yadav

    Extract found to contain search terms

    Homology modelling and docking studies has been mainly done to identify the interaction and binding affinity of previous drugs and how they could act as a potential solution to stop the overall spread of the disease in case of pandemic like COVID

    545
    Downloads
    Category: Biological and Medicinal Chemistry
    , Title:

    Treatment of COVID-19 patients: Justicia adhatoda leaves extract is a strong remedy for COVID-19 – Case report analysis and docking based study

    , Authors: Abhrajit Bag, Arijit Bag

    Extract found to contain search terms

    Key words: COVID -19, Structure of COVID -19, Infection mechanism of COVID -19, Model drugs for COVID

    3,999
    Downloads
    Category: Biological and Medicinal Chemistry
    , Title:

    Amodiaquine as COVID-19 Mpro Inhibitor: A Theoretical Study

    , Authors: BN Acharya

    Extract found to contain search terms

    COVID -19 is caused by severe respiratory syndrome –coronavirus 2 (SARS CoV-2). This has been declared as a global pandemic by World Health Organization (WHO). Currently only supportive care is available for treatment of patients. However availability of direct therapeutic approaches would greatly benefit the patient care and reduce death among COVID - 19 patients. Repurposing of approved drugs against COVID -19 would be a faster method to identify direct therapeutics against COVID -19. This study describes screening and identification of Amodiaquine a known antimalarial as COVID

    534
    Downloads